A groundbreaking study recently published in the New England Journal of Medicine has shown that a combination of two existing biologic drugs can stop the progression of multiple myeloma, a serious type of blood cancer.
Informatie preluata din publicatia "Bursa" - citeste integral articolul - click aici
Web Design by Dow Media | Gazduire Web by SpeedHost.ro